 |
 |
|
 |
|
Research and Development (R&D) has been
positioned as Nissan Chemical’s key driver
of business growth. The Company has
successfully developed unique and excellent
technology and delivered a variety of high
value-added products into the market.
As a value creation company, we will promote
the creation of specialty products that are
full of originality to satisfy our customer
needs, and continue pursuing our Dream of
Chemicals. |
|
|
|
 |
|
 |
|
|
|
|
|
|
 |
By building on and utilizing our specialized
technologies such as fine organic synthesis
and nanoparticle control, we are continuing
the development of new products, as well
as designing new applications for existing
products, such as the inorganic silicasol
SNOWTEX and special epoxy resin TEPIC, in
order to respond to the needs of the market
in cutting edge fields. In addition,
in order to accelerate the creation and development
of the next generation of business and materials
Nissan Chemical Industries has formed a top-level
organizational partnership with Kyushu University,
the largest such partnership between a company
and a university in Japan. Cooperative
research is continuing into new nanoparticle
fields, as an independent organization under
the direct control of the President. |
|
| |
|
|
|
Utilizing our unique polymer technology,
research and development is continuing into
cutting edge electronic materials for use
with displays and semiconductors. Our
core products, the polyimide SUNEVER for
LCD displays, and bottom anti-reflective
coating (BARC) for semiconductors, have established
a solid reputation for high quality in a
variety of fields. We continue to develop
new materials targeting the cutting edge
display and semiconductor fields. |
|
| |
|
|
|
As a result of our R&D, we have created
the herbicides, TARGA, SIRIUS and PERMIT,
and the acaricide SANMITE, which are all
significant contributions to the world agricultural
industry. A fungicide, LEIMAY, and
an acaricide, STARMITE were launced in 2008
and in 2009 respectively. Additionally,
we are advancing research on the effects,
safety and manufacture of active ingredients
for promising new chemicals.
| |
| |
PHARMACEUTICALS
|
 |
|
|
|
With a focus on new drug development to meet
the needs of an aging society, the Company
introduced its first new medicine, efonidipine
hydrochloride (LANDEL®), a Ca antagonist
targeting hypertension in 1994, and pitavastatin
calcium (LIVALO®), a statin agent with
a strong LDL cholesterol reduction targeting
hyperlipidemia, was introduced to Japanese
market in 2003. It is also introduced
to Asian countries, such as South Korea,
Thailand and China, and has been approved
in the United States in 2009. Further, it
has been applied for approval in Europe.
Concerning the new drug development pipeline,
a therapeutic drug for peripheral arterial
disease (NM/NT/INDI-702) is in the process
of clinical development in Japan and in the
United States, and a therapeutic and preventive
drug for atrial fibrillation and flutter
(NTC-801) is also in the process of clinical
development in Japan. In 2009, the
clinical development with a new therapeutic
agent for thrombocytopenia (NIP-022) has
been started in the United States.
We keep trying R&D for innovative medicines
by using the strategic chemical library,
the state-of-the-art evaluation technology
and precision organic synthesis technology.
|
|
| |
 |
|
 |
|
| With the goal of becoming a distinctive Value
Creation Enterprise, our corporation continues
unique R&D activities at our four domestic
focal bases, while simultaneously developing
collaborative research and/or technical collaboration
with domestic and overseas universities,
public research institutions as well as corporations.
In addition, product planning and experimental
research has been carried out globally at
an agricultural chemicals testing farm in
Indiana, the United States, and through other
joint ventures. |
|
 |
|
|
|
| |
CHEMICAL RESEARCH LABORATORIES
|
|
|
|
|
Chemical Research Laboratories have become general research and development bases committed to the search for new products, the development of new agricultural chemicals and pharmaceuticals, pharmaceutical intermediates and active ingredients, special organic materials, synthetic studies and process development for high-polymer material intermediates and material analysis research based on organic synthesis expertise accumulated over years.
We are promoting new product and technology development based on close cooperation with other laboratories and the technology divisions of affiliated plants. |
 |
|
| |
ELECTRONIC MATERIALS RESEARCH LABORATORIES
|
|
|
|
|
Electronic Materials Research Laboratories are carrying out research on the next generation of recording and optical networking materials along with R&D on display and semiconductor materials.
We are presently researching alignment coating for LCD panels using our unique polyimide, anti-reflective coatings used in the photolithography process, and inorganic coatings formed through the sol-gel process.
At Toyama laboratories, which were completed
in 2002 with a class 1 clean room and advanced
evaluation equipment in Toyama Factory,
we are pursuing research on the development
of next-generation semiconductor materials.
In 2007 spring, new facilities for electronic
materials research were completed in Funabashi
City, Chiba. Studies on display materials
and creation of innovative electronic materials
are the focus of R&D in Funabashi laboratories. |
 |
|
| |
SPECIALTY MATERIALS RESEARCH LABORATORIES
|
|
|
|
|
We are promoting R&D on inorganic materials at the Sodegaura Plant and organic materials at the Chemical Research Laboratories.
In the inorganic materials area, we are putting
our efforts into manufacturing metal-oxide
sol, developmental research for its use,
including silicasol utilizing super fine
particle control technology, and developmental
research on abrading agents and inorganic
electrical conducting material research based
on these sol. In addition, in the area
of organic materials, we are promoting developmental
research on the manufacturing and use of
epoxy resin reforming agents and cross-linking
agents for fine particle coatings. |
 |
|
| |
BIOLOGICAL RESEARCH LABORATORIES
|
|
|
|
|
Biological Research Laboratories are conducting research on drug efficacy evaluation, safety evaluation and environmental analysis for agricultural chemicals and pharmaceuticals.
In the agricultural chemicals area, we are
conducting research on commercialization,
including existing active ingredients and
active ingredients to be introduced paying
attention to user requirements and the direction
of the market along with the discovery of
new agricultural chemicals that are eco-friendly
with high efficacy and safety through the
main research mentioned above. We are
promoting new chemical evaluation focused
on the research field overseas in Indiana
in the United States and a joint venture
with the Philagro France research center.
In the pharmaceutical area, we are working toward the discovery of therapeutic agents that are gentle to the human body by carrying out pharmacological tests from the genetic level to pathological models, safety and ADME testing. |
 |
|
|
Basic Chemicals
